Stocks
Intra-Cellular Therapies (ITCI) R&D US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D, bln rub | 89.1 | 65.8 | 88.8 | 134.7 | 180.1 | 185.0 | |||
| Changes by years, y/y, % | -33% | -26% | +35% | +52% | +34% | +6.4% | |||
Intra-Cellular Therapies. R&D, bln rub
Intra-Cellular Therapies. R&D, changes, %
Intra-Cellular Therapies. R&D, sum by quarters, bln rub
Intra-Cellular Therapies (ITCI) R&D US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| R&D, bln rub | 38.0 | 49.8 | 41.6 | 50.8 | 42.8 | 185.0 | ||
| Changes by years, y/y, % | +31% | +29% | +25% | +50% | +13% | |||
| Changes by quarters, q/q, % | +12% | +31% | -17% | +22% | -16% | |||
